Glassman Wealth Services Exelixis, Inc. Transaction History

Glassman Wealth Services

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$19.25 - $24.13 $442 - $554	23 Added 9.06%	277 $6,000
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $1,028 - $1,227	-54 Reduced 17.53%	254 $5,000
Q2 2023 Aug 08, 2023	BUY	$18.17 - $20.48 $981 - $1,105	54 Added 21.26%	308 $5,000
Q1 2023 May 04, 2023	BUY	$16.3 - $19.41 $277 - $329	17 Added 7.17%	254 $4,000
Q4 2022 Feb 06, 2023	SELL	$14.96 - $17.39 $1,271 - $1,478	-85 Reduced 26.4%	237 $3,000
Q3 2022 Nov 09, 2022	SELL	$15.68 - $22.27 $10,442 - $14,831	-666 Reduced 67.41%	322 $5,000
Q2 2022 Aug 04, 2022	BUY	$17.44 - $23.16 $3,435 - $4,562	197 Added 24.91%	988 $21,000
Q1 2022 Apr 14, 2022	BUY	$17.03 - $22.67 $13,317 - $17,727	782 Added 8688.89%	791 $18,000
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $5,216 - $6,764	-320 Reduced 97.26%	9 $0
Q4 2020 Feb 04, 2021	SELL	$18.39 - $24.8 $312 - $421	-17 Reduced 4.91%	329 $7,000
Q3 2020 Nov 09, 2020	BUY	$20.67 - $26.94 $4,712 - $6,142	228 Added 193.22%	346 $8,000
Q2 2020 Aug 06, 2020	BUY	$16.46 - $27.42 $1,794 - $2,988	109 Added 1211.11%	118 $3,000
Q1 2020 May 12, 2020	BUY	$14.46 - $21.8 $14 - $21	1 Added 12.5%	9 $0
Q4 2019 Feb 07, 2020	BUY	$15.15 - $18.89 $121 - $151	8 New	8 $0
Q2 2019 Aug 08, 2019	SELL	$18.93 - $24.75 $227 - $297	-12 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$13.65 - $21.8 $163 - $261	12 New	12 $0
Q1 2018 May 01, 2018	SELL	$22.15 - $31.89 $221 - $318	-10 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$24.23 - $30.93 $242 - $309	10	10 $0

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.